(Q38171461)

English

Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis

scientific article published on July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

0 references

Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

30 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pneumococcal vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Bernard Combe

1 reference

Europe PubMed Central

30 August 2017

author name string

Charlotte Hua

1

1 reference

Europe PubMed Central

30 August 2017

Thomas Barnetche

2

1 reference

Europe PubMed Central

30 August 2017

Jacques Morel

4

1 reference

Europe PubMed Central

30 August 2017

publication date

1 July 2014

1 reference

Europe PubMed Central

30 August 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

30 August 2017

66

1 reference

Europe PubMed Central

30 August 2017

7

1 reference

Europe PubMed Central

30 August 2017

1016-1026

1 reference

Europe PubMed Central

30 August 2017

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Vaccinate your immunocompromised patients!

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Vaccinations in patients with immune-mediated inflammatory diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

1 reference

https://api.crossref.org/works/10.1002%2FACR.22246

21 January 2018

Identifiers

10.1002/ACR.22246

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38171461&oldid=2128385753"